We have established a systematic screen for imprinted genes using a subtraction-hybridization method with day 8.5 fertilized and parthenogenetic embryos. Two novel imprinted genes, Peg1/Mest and Peg3, were identified previously by this method, along with the two known imprinted genes, Igf2 and Snrpn. Recently three additional candidate imprinted genes, Peg5-7, were detected and Peg5 is analyzed further in this study. The cDNA sequence of Peg5 is identical to Neuronatin, a gene recently reported to be expressed mainly in the brain. Two novel spliced forms were detected with some additional sequence in the middle of the known Neuronatin sequences. All alternatively spliced forms of Peg5 were expressed only from the paternal allele, confirmed using DNA polymorphism in a subinterspecific cross. Peg5/Neuronatin maps to sub-distal Chr 2, proximal to the previously established imprinted region where imprinted genes cause abnormal shape and behavior in neonates.
INTRODUCTION
Proper development in mammals requires both a maternal and a paternal genome because of the presence of imprinted genes whose expression is dependent on their parental origin (1) (2) (3) . From genetic studies, chromosomes 2, 6, 7, 11, 12 and 17 have been identified in the mouse as chromosomes whose influence on development is dictated by their parental origin (4) and the responsible regions have been narrowed down to nine established imprinted regions on these chromosomes. Several imprinting effects were observed following maternal or paternal duplication of these established imprinted regions, such as early embryonic lethality, mid fetal lethality, neonatal lethality, excessive or deficient prenatal growth, excessive or deficient postnatal growth and hyperkinetics or hypokinetics in neonates with different morphological abnormalities. Therefore, each of these regions must contain imprinted gene(s). Seventeen imprinted genes have been identified in the mouse (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) , most of which map to these imprinted regions. The majority of these genes are also imprinted in humans (18) . However, the biological significance and molecular mechanism of genomic imprinting in mammals remains to be elucidated. To clarify common features of imprinted genes, such as biochemical function or expression specificity, it is necessary to identify and characterize additional imprinted genes. We have established a genome wide systematic screen for new imprinted genes using parthenogenetic and normal mouse embryos at 8.5 days postcoitum (d.p.c.) as the source of material (11) . Two novel imprinted genes, Peg1/Mest (11) and Peg3 (12) have been isolated previously with our cDNA subtractive hybridization and differential screening method. Here we demonstrate that Peg5, which is identical to neuronatin, is also imprinted. Neuronatin is expressed in the nervous system especially in the hindbrain and pituitary gland during development and is highly conserved among the three mammalian species, rat, mouse and human (19, 20) . We have mapped this gene to sub-distal mouse Chr 2, proximal to the previously established imprinted region (distal Chr 2) affecting development, behavior and viability in neonates (21) .
MATERIALS AND METHODS

Peg5/Neuronatin
The DNA sequence of Peg5/Neuronatin-5 was registered on DDBJ with accession number AB004048.
Expression analysis using RT-PCR
Total RNA was extracted from day 9.5 fertilized embryos (males and females) and parthenogenetic embryos of (C57BL/6 × C3H) F 1 (Fig. 1a) using ISOGEN (Nippon Gene) as described previously (11, 12) . Reverse transcription was carried out using 100 ng of total RNA isolated from each embryo. One hundredth of the cDNA sample was used for amplification of Peg5/Neuronatin-2, 3, 4, 5 *To whom correspondence should be addressed. Tel: +81 45 924 5812; Fax: +81 45 924 5814; Email: fishino@bio.titech.ac.jp (20) . In our analysis of Peg5/Neuronatin-5, the sequence was almost the same as the published data, except in four sites (deletions, addition and base change) resulting in a 964 bp region instead of a 962 bp region, and an extra 13 bp sequence at the 3′ end that is also reported in the rat Neuronatins (19, 30) . The total number of nucleotides in Peg5/Neuronatin-4 and 5 is based on our results (indicated by w). and one thousandth for β-actin. Reaction mixtures contained 1× ExTaq buffer, 2.5 mM dNTP mixture, 80 pmol primers and 2.5 U ExTaq (Takara) in 100 µl, and the amplification cycle was set at 95_C for 30 s, 65_C for 30 s and 72_C for 60 s in a Perkin-Elmer GeneAmp PCR system 9600. Primer sets used were 5i-CAGAA-CTGCTCATCATCGGC-3i (F4) and 5i-TGCGTGAGACCAG-GGATAAG-3i (R1), 5i-ACTTGCCAAGGTCAGTGAGG-3i (F5) and 5i-TCATGGTAGGATCTTGTG CG-3i (R3) for Peg5/Neuronatin-2 and 3 and 5i-AGCCGGGAACAAAGACTCAG-3i (F2) and R1 for Peg5/Neuronatin-4 and 5. β-actin (222 bp) was amplified as a control using primers 5i-AAGTGTGACGTTGA-CATCCG-3i and 5i-GATCCACATCTGCTGGAAGG-3i. For analysis of neonatal organs and tissues (Fig. 3) , one hundredth of the cDNA samples was amplified for 30 cycles for Peg5/Neuronatin-2, 3 and 35 cycles for Peg5/Neuronatin-4, 5, respectively.
RFLP analysis
Total RNA from adult brains (C3H, C57BL/6 and MSM), neonatal brains (C57BL/6 × MSM) F 1 and reciprocal F 1 of [(MSM × C57BL/6) F 1 ] and day 13 whole embryos [(C3H × MSM) F 1 ] were used for RT-PCR. For Peg5/Neuronatin-2 and 3, the first 25 cycles of amplification were carried out using F4 and R1. After confirming that only Peg5/Neuronatin-2 and 3 had been amplified, one hundredth of the samples was reamplified for another 13 cycles with primers F5 and R3. For Peg5/Neuronatin-4 and 5, the first amplification was for 25 cycles. Then, one hundredth of the samples was reamplified for another 13 cycles with the same primers. PCR products were digested with TaqI restriction enzyme at 65_C for 4 h.
RESULTS
Identity of Peg5 with Neuronatin and analysis of alternatively spliced forms
DNA sequence analysis showed that Peg5 cDNA is identical to the previously described mouse neuronatin (20) . It also shares significant homology to rat and human Neuronatin (20) . Peg5 cDNA has an additional 275 bp in the coding region and this transcript seems to be the largest of the alternatively spliced forms of Neuronatin (Fig. 1a) . We detected four transcripts of Peg5/Neuronatin by RT-PCR, designated Peg5/Neuronatin-2, 3, 4 and 5 in ascending order of the size of the transcript. Peg5/Neuronatin-2 and 3 were named after the previously isolated mouse neuronatin-2 and 3 (20) and correspond to the rat Neuronatin-β and α (19) . Peg5/Neuronatin-4 and 5 are novel transcripts that have an additional 275 bp of sequence; the original cDNA identified as Peg5 corresponds to Peg5/Neuronatin-5. Comparing several RT-PCR products with corresponding PCR products of genomic DNA, there are apparently two introns between 275 and 81 bp and between 81 and 964 bp regions. However, no intron seems to exist between the 138 and 275 bp sequences. DNA sequence of the genomic DNA confirmed this result (Fig. 1a) . This indicates two possible usages of exon 1; the 275 bp sequence in the 3i part of exon 1 is spliced out to produce Peg5/Neuronatin-2 and 3, while it is read through from the preceding 138 bp sequence to produce Peg5/Neuronatin-4 and 5.
Peg5/Neuronatin-2 and 3 encode peptides that consist of 54 and 81 amino acids, respectively (19, 20) , and both Peg5/Neuronatin-4 and 5 have the same open reading frame of 44 amino acids because a stop codon appears within the 275 bp sequence. All peptides have a common N-terminal amino acid sequence of 24 residues, most of which are hydrophobic residues that may form 2) and female (lanes 3 and 4), and in day 9.5 parthenogenetic (C57B/6 × C3H) F 1 embryos (lanes 5-7). PCR amplification of Peg5/Neuronatin-2 and 3 (upper) consisted of 30 cycles using primers F4-R1. Peg5/Neuronatin-4 and 5 (middle) were amplified for 30 cycles using primers F2-R1 and reamplification was carried out for 10 more cycles using one tenth of the aliquot. β-actin (lower) was amplified to serve as a control. After confirming that only Peg5/Neuronatin-2 and 3 were amplified, a second round of PCR was carried out using internal primers F5-R3, because one TaqI fragment from the F4-R1 region was similar to the 82 bp in question. (g) For Peg5/Neuronatin-4 and 5, amplification was carried out using the F2-R1 primers, followed by TaqI digestion. a transmembrane region (19, 20) . Peg5/Neuronatin-2 and 3 have common C-terminal sequences of 30 amino acids; the latter has an additional 27 amino acid sequence in the middle ( Fig. 1c; 19,20) . Peg5/Neuronatin-2 and 3 peptides have four and five putative phosphorylation sites for protein kinase C (22, 23) in the C-terminal region, respectively (Thr and Ser; asterisks in Fig. 1c) . Peptides encoded by both of Peg5/Neuronatin-4 and 5 have C-terminal sequences consisting of 20 amino acids that differ entirely from the Peg5/Neuronatin-2 and 3 C-terminal amino acid sequences. There is also one candidate for a sulfatation site (24) (Tyr; asterisks in Fig. 1c) , although its significance is unknown.
Expression and imprinting of Peg5/Neuronatin
We examined the expression and imprinting status of all of the Peg5 transcripts. Only the expression of Peg5/Neuronatin-2 and 3 could be detected by RT-PCR using the F4-R1 primer set (Fig. 1b) , indicating that expression levels of Peg5/Neuronatin-4 and 5 are very low compared with those of Peg5/Neuronatin-2 and 3 (see below and Fig. 2 legend) . Peg5/Neuronatin-4 and 5 were amplified specifically using the primer set, F2-R1 (Fig. 1b) , because the F2 primer was designed within the 275 bp region. As shown in Figure 2a , all transcripts were expressed only in normal embryos and not in parthenogenetic embryos. All four transcripts are expressed from the paternal allele only. This was determined by analyzing subinterspecific hybrid embryos using a DNA polymorphism in the 3i UTR (shown in Fig. 2f and g ) in Mus musculus molossinus (MSM) and Mus musculus musculus strains of C57BL/6 and C3H mice (Fig. 2b-e) . A MSM-specific TaqI site is contained within the 82 bp TaqI fragment from B6 or C3H cDNA and gives 40 and 42 bp fragments from MSM cDNA when digested with TaqI together with the other TaqI fragments indicated in Figure 2f and g. In day 13.5 embryos of (C3H × MSM) F 1 , only the MSM (paternal) alleles of Peg5/Neuronatin-2 Figure 3 . Analysis of Peg5 expression in neonatal tissues. Primers were used as described in Figure 1b and conditions of RT-PCR were the same as described in the legend to Figure 2a . Except for the lung, no expression was detected in other tissues and organs, including stomach, liver, spleen, thymus, heart, muscle and tongue. and 3 (Fig. 2b) or Peg5/Neuronatin-4 and 5 ( Fig. 2c) were detected. In neonatal brain of (B6 × MSM) F 1 and the reciprocal (MSM × B6) F 1 , only paternal alleles (MSM for the former and B6 for the latter) were detected for both Peg5/Neuronatin-2 and 3 ( Fig. 2d) and Peg5/Neuronatin-4 and 5 ( Fig. 2e) Brain specific expression of Neuronatin during development was examined in detail using in situ hybridization by Wijnholds et al. (20) . We confirmed their results by carrying out the same experiment using our Peg5/Neuronatin-5 probe that has an additional 275 bp of sequence. RT-PCR analysis on neonates also showed that all four transcripts were expressed mainly in the brain and eyes; very low expression was detected in the bladder, colon (Fig. 3e ) and lung (data not shown). The expression levels of Peg5/Neuronatin-2, 3 were always higher than those of Peg5/Neuronatin-4 and 5 (estimated at ∼50-100-fold by RT-PCR). There were subtle differences in the levels of expression of various transcripts, but the sites of their expression appear to be similar. However, it is possible that only certain transcripts may be expressed in embryos prior to day 8.5 in the mouse because Joseph et al. reported that rat Neuronatin-α, corresponding to our Peg5/Neuronatin-3, was only expressed in day 7-10 embryos (19) .
Mapping of Peg5/Neuronatin to sub-distal chromosome 2
Mapping of Peg5/Neuronatin was carried out using linkage analysis as shown in Figure 4 . The gene maps to distal Chr 2. An imprinted region was previously detected here based on genetic studies using the T2Wa translocation breakpoint to generate embryos of different genotypes. Neonatal mice with duplication of maternal Chr 2 and paternal deficiency (MatDp.dist2. T2Wa) have thin bodies with arched backs and are hypokinetic, while the PatDp.dist2. T2Wa have square bodies and show hyperkinetic movement (25) . Both of these conditions are neonatal lethal and this provides evidence for the existence of imprinted gene(s) on distal Chr 2. Indeed, Gnas which maps to this region has previously been reported to be imprinted (26) . Peg5/Neuronatin must be proximal to Gnas (see Fig. 4 legend) . As shown in Figure 4 , Peg5/Neuronatin is also proximal to Ada. This mapping data may have important implications for defining the imprinted region on distal Chr 2, as Ada is proximal to the T2Wa breakpoint (Peters, J., personal communication). Thus, Peg5/Neuronatin Figure 4 . Mapping of Peg5. Linkage analysis was carried out with a total of 254 mice of the subinterspecific backcross (DBA × MSM)F 1 × MSM using the TaqI polymorphism in the 3i UTR as described in the legend to Figure 2 . The ratios of the total number of mice exhibiting recombinant chromosomes to total number of mice analyzed for each pair of loci is -D2Mit22-6/255-D2Mit48-5/254-Peg5/Neuronatin-2/254-D2Mit411-1/254-D2Mit453-2/254-D2Mit197-7/254-Ada-0/254-D2Mit29-1/254-D2Mit49-16/255-D2Mit25. The calculated genetic distances in centiMorgans (cM) are shown. Gnas is located distal to D2Mit25 (31) , indicating that the location of Peg5/Neuronatin is very different from that of Gnas. Moreover, the Peg5/Neuronatin locus is proximal to Ada which is proximal to the T2Wa breakpoint (Peters, J., personal communication). An imprinted region that affects neonatal viability and behavior is located distal to T2Wa, suggesting that Peg5/Neuronatin maps to a novel imprinted region. may be proximal to the T2Wa breakpoint and also proximal to the previously identified imprinted region affecting neonatal behavior.
DISCUSSION
Systematic screening for paternally expressed genes (Peg) has been carried out using a subtraction-hybridization method with day 8.5 fertilized and parthenogenetic embryos. So far, two novel imprinted genes, Peg1/Mest (11) and Peg3 (12), have been identified along with the two known imprinted genes, Igf2 (27) and Snrpn (13) . These four imprinted genes map to four independent imprinted regions, proximal Chr 6 (Peg1/Mest), proximal Chr 7 (Peg3), distal Chr 7 (Igf2) and central Chr 7 (Snrpn). In this study, we analyzed Peg5/Neuronatin and mapped it to sub-distal Chr 2. It is noteworthy that five imprinted genes that are located in five different imprinted regions were obtained with our subtraction-hybridization method and these results indicate that this subtraction method is a very powerful tool for the isolation of differentially expressed genes from very small amounts of biological tissues.
Peg5/Neuronatin is highly expressed in the brain during development and also in neonates and adults. Our initial mapping data suggest that Peg5/Neuronatin is located on distal Chr 2, a region that has been implicated in neonatal behavior and viability (21) and it seems that Peg5/Neuronatin might be a good candidate to explain these phenotypes. However, more precise mapping data has suggested that it is located proximal to and outside the established imprinted region. There have been no reports suggesting the existence of an imprinted region at this locus by previous genetic studies. However, recently, a novel imprinted gene, Grf1, was isolated by the RLGS (restriction landmark genome scanning) method and was mapped to Chr 9, where no imprinted region had previously been detected by genetic studies (16) . It is noteworthy that the majority of the imprinted genes so far identified are located within genetically defined imprinted regions. However, since not all imprinted genes will necessarily produce a distinct phenotype, it is possible that other novel imprinted genes may exist in regions not identified by genetic studies. Thus, systematic screening for paternally expressed genes has led to the discovery of a novel imprinted region in the mouse.
In this study, we identified four alternatively spliced forms of Neuronatin. Three different forms of Neuronatin, neuronatin-1, 2 and 3 have been reported previously (20) . Neuronatin-2 and 3 are identical to our Peg5/Neuronatin-2 and 3. Two novel alternatively spliced forms, Peg5/Neuronatin-4 and 5, have some additional sequence. The expression pattern of these two transcripts appeared to be the same as that of Peg5/Neuronatin-2 and 3. The first exon which includes both the 138 bp and the 275 bp sequence is used in two different ways. Firstly, it is used as an exon of 138 bp for Peg5/Neuronatin-2 and 3. Secondly, it is used as a continuous 403 bp exon for Peg5/Neuronatin-4 and 5 by reading through from the 138 bp sequence to the 275 bp segment. A similar splicing pattern is seen in three transcripts of polyoma T antigen genes (28) .
Because there have been no reports of genetic studies using mice showing uniparental disomy of the sub-distal region of chromosome 2 where Peg5/Neuronatin is located, the function of Peg5/Neuronatin is currently unclear. It will be very interesting to identify the function of Peg5/Neuronatin in neural cells during development. All of the alternatively spliced transcripts encode short polypeptides that have a common N-terminal putative transmembrane region consisting of 24 hydrophobic amino acids. Peg5/Neuronatin-2, 3 peptides consist of a total of 54 and 81 amino acids, respectively (19, 20) , while both Peg5/Neuronatin-4 and 5 have the same open reading frame of a total of 44 amino acids. Peg5/Neuronatin-2, 3 peptides have four and five putative phosphorylation sites for protein kinase C, respectively (22, 23) in the C-terminal region, and peptides encoded by both of Peg5/Neuronatin-4, 5 have one candidate sulfatation site (24) in their C-terminal sequence. These structural features suggest that the C-terminal region may extend into the cytoplasm and that the Peg5/Neuronatin peptides might function as membrane channels or membrane receptors (19, 20) for signal transduction, perhaps by forming multimers or a complex with other protein(s). Recently, it has been reported that the amino acid sequence of human neuronatin shows 50% homology with two ion channel proteins, PMP1 and phospholamban, that function as subunits of an H + -ATPase and a Ca 2+ -ATPase, respectively (29) . It seems likely that Peg5/Neuronatin has an essential role in brain development or neuronal function as it is highly conserved among mammalian species (19, 20, 30) . Detailed investigations from genetic, molecular and cellular viewpoints will be required to elucidate the role of the Peg5/Neuronatin gene.
